- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01964612
Illness Crisis Adapting in Early or Middle Phase of Patient With Chronic Disease: Study of Meta-cognition Model
October 14, 2013 updated by: National Taiwan University Hospital
Patient with chronic disease learning of a chronic illness quickly changes the way they encounter in physiological, psychological and social aspects.
The investigators research purposes will use the meta-cognitive approach to explore adjustment to life-threatening illness (ex.
hypertension and diabetes) of patients may find the important factors in their coping process.
Study Overview
Status
Unknown
Conditions
Detailed Description
Patient with chronic disease learning of a chronic illness quickly changes the way they encounter in physiological, psychological and social aspects.
They need adjust themselves and their crisis lives, and some plan they had made the near or distant future.
The investigators research purposes will use the meta-cognitive approach to explore adjustment to life-threatening illness (ex.
hypertension and diabetes) of patients may find the important factors in their coping process.Research methods will separate three year project to describe.
First year project will use qualitative methods from bio-psychosocial aspects to interview participants who may suffer illness after diagnosis or stable treatment during middle phase of illness.
Second year will invite diabetes and hypertension patients from different phase of illness with different levels of health anxiety trait, meta-cognitive and control strategies if derived different coping and emotions outcome.
The third year will design motivational psycho-education program for patients to alleviate the emotions and use cold meta-cognition to due good health behavior and self care with their illness.
The expected results will like to test the investigators new model in caring chronic disease patients.
Study Type
Observational
Enrollment (Anticipated)
460
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- National Taiwan University Hopital
-
Contact:
- Bee-Horng Lue, MD
- Phone Number: 886-2-23123456
- Email: grace@ntu.edu.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
adults with obvious chronic diseases of hypertension or diabetes, or both diseases diagnosed by doctors in Taiwan.
Description
Inclusion Criteria:
- adults aged 20 and above, with hypertension or diabetes or both diseases.
Exclusion Criteria:
- adults with other severe physical diseases.
- adults with relevant psychological diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
self-monitoring and self-control scale
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
meta-thinking awareness scale
Time Frame: one year
|
one year
|
negative self thinking scale
Time Frame: one year
|
one year
|
depression and anxiety scale
Time Frame: one year
|
one year
|
life change scale
Time Frame: one year
|
one year
|
health anxiety scale
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Bee-Horng Lue, MD, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
October 8, 2013
First Submitted That Met QC Criteria
October 14, 2013
First Posted (Estimate)
October 17, 2013
Study Record Updates
Last Update Posted (Estimate)
October 17, 2013
Last Update Submitted That Met QC Criteria
October 14, 2013
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201205106RIC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug or Chemical Induced Diabetes Mellitus
-
Beijing 302 HospitalCompletedDrug-induced Liver Injury,ChronicChina
-
Beijing 302 HospitalCompletedDrug-induced Liver Injury,ChronicChina
-
Jaseng Hospital of Korean MedicineCompletedMusculoskeletal Diseases | Drug-Induced Liver InjuryKorea, Republic of
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCRecruitingDrug Interaction | Drug Induced Liver Injury | CannabidiolUnited States
-
Kennon HeardMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.CompletedDrug Induced Liver InjuryUnited States
-
Dr. Frank BehrensBionorica SEActive, not recruitingDrug-induced Liver InjuryGermany
-
University of North Carolina, Chapel HillCompletedDrug Induced Liver InjuryUnited States
-
Beijing 302 HospitalUnknownDrug-Induced Liver InjuryChina
-
University of Cape TownMedical Research Council, South AfricaCompletedDrug-Induced Liver InjurySouth Africa
-
Seoul National University HospitalCompletedHealthyKorea, Republic of